Author(s): Rama Mohammad Ramzy Kattan, Djamila Ben Hadda, Amir Balash, Mustapha Fawaz Chehna

Email(s): kttnrama@gmail.com , mf.chehna@gmail.com , djamila.benhadda@ebla.edu.sy , balasha@staff.uni-marburg.de

DOI: 10.52711/0974-360X.2024.00264   

Address: Rama Mohammad Ramzy Kattan1, Djamila Ben Hadda2, Amir Balash3, Mustapha Fawaz Chehna1* 1Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, University of Aleppo, Aleppo, Syria.
2Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, Ebla Private University, Aleppo, Syria.
3Department of Pharmaceutical Chemistry, Institute of Pharmacy, Philipps-Universität Marburg, Marburg, Germany.
*Corresponding Author

Published In:   Volume - 17,      Issue - 4,     Year - 2024


ABSTRACT:
Researchers have discovered that tyrosine kinase plays a significant role in cancer development. As a result, certain studies focused on synthesizing sulfonamide compounds due to their potent tyrosine kinase inhibitory (TKI). The designed compounds were docked against (HER2) human epidermal growth factor receptor 2 (PDB ID: 3pp0) to identify potential prospects for new cancer drugs. Docking studies using Molegro virtual docker (MVD) revealed the most favorable binding energy among our compounds. In total, all synthesized compounds had binding energies ranging from (-112.893 to -154.396kcal/mol) corresponding to (3a and 1a) respectively. It was found that compound 1a possessed the best binding energy value of synthesized compounds (-154.396 kcal/mol) compared to the recommended drug; trastuzumab (-133,419kcal/mol). Several of the newly designed sulfonamide derivatives were synthesized. An alkaline phase was used in our synthesis to combine some amino acids, sulfamethoxazole, and sulfadiazine with benzenesulfonyl chloride derivatives. The synthesis method was simple and cheap with yields ranging between (60.4% - 80%). Nuclear magnetic resonance spectroscopy, mass spectrometry, and infrared spectroscopy were used to characterize our compounds.


Cite this article:
Rama Mohammad Ramzy Kattan, Djamila Ben Hadda, Amir Balash, Mustapha Fawaz Chehna. Design, Facile synthesis, and Characterization of sulfonamide derivatives combined with amino acids and other drugs targeting HER2. Research Journal of Pharmacy and Technology.2024; 17(4):1667-3. doi: 10.52711/0974-360X.2024.00264

Cite(Electronic):
Rama Mohammad Ramzy Kattan, Djamila Ben Hadda, Amir Balash, Mustapha Fawaz Chehna. Design, Facile synthesis, and Characterization of sulfonamide derivatives combined with amino acids and other drugs targeting HER2. Research Journal of Pharmacy and Technology.2024; 17(4):1667-3. doi: 10.52711/0974-360X.2024.00264   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-4-38


REFERENCES:
1.    Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet.  2020; 396(10258): 1204-1222.
2.    El-Deeb, I.M., et al. Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction. European Journal of Medicinal Chemistry. 2010; 45(6): 2516-2530.
3.    Wan, Y., et al. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. Eur J Med Chem. 2021; 226:  113837.
4.    Luo, Y., et al. Metronidazole acid acyl sulfonamide: A novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors. Bioorganic and Medicinal Chemistry. 2011; 19(20): 6069-6076.
5.    Kolibaba, K.S. and B.J. Druker. Protein tyrosine kinases and cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 1997; 1333(3): F217-F248.
6.    Paul, M.K. and A.K. Mukhopadhyay, Tyrosine kinase–role and significance in cancer. International Journal of Medical Sciences. 2004; 1(2): 101.
7.    Akili, S., et al. Design, Synthesis and Characterization of Novel Sulfonamides Derivatives as Anticancer Agent Targeting EGFR TK, and Development of New Methods of Synthesis by Microwave Irradiation. International Journal of Organic Chemistry. 2021. 11(4): 199-223.
8.    Akili, S., et al. Computer-Aid Design of Novel Sulfonamide Derivatives as EGFR Kinase Inhibitors for Cancer Treatment. International Journal of Organic Chemistry. 2021; 11(4): 171-186.
9.    Connors, T. and W. Ross, Some sulfur containing amino-acids of biological interest. Biochemical Pharmacology. 1958; 1(1): 93-100.
10.    Cremlyn, R.J.W., Chlorosulfonic acid. 2002: Royal Society of Chemistry.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available